JP2023505169A5 - - Google Patents

Info

Publication number
JP2023505169A5
JP2023505169A5 JP2022533108A JP2022533108A JP2023505169A5 JP 2023505169 A5 JP2023505169 A5 JP 2023505169A5 JP 2022533108 A JP2022533108 A JP 2022533108A JP 2022533108 A JP2022533108 A JP 2022533108A JP 2023505169 A5 JP2023505169 A5 JP 2023505169A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
interferon
agonist
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022533108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505169A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/083737 external-priority patent/WO2021110561A1/en
Publication of JP2023505169A publication Critical patent/JP2023505169A/ja
Publication of JP2023505169A5 publication Critical patent/JP2023505169A5/ja
Pending legal-status Critical Current

Links

JP2022533108A 2019-12-03 2020-11-27 B型肝炎感染の治療における使用のためのインターフェロン会合抗原結合タンパク質 Pending JP2023505169A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19306551.3 2019-12-03
EP19306551 2019-12-03
EP19306572.9 2019-12-04
EP19306572 2019-12-04
PCT/EP2020/083737 WO2021110561A1 (en) 2019-12-03 2020-11-27 Interferon-associated antigen binding proteins for use in treating hepatitis b infection

Publications (2)

Publication Number Publication Date
JP2023505169A JP2023505169A (ja) 2023-02-08
JP2023505169A5 true JP2023505169A5 (enExample) 2023-12-05

Family

ID=73554457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022533108A Pending JP2023505169A (ja) 2019-12-03 2020-11-27 B型肝炎感染の治療における使用のためのインターフェロン会合抗原結合タンパク質

Country Status (10)

Country Link
US (1) US20230028476A1 (enExample)
EP (1) EP4069290A1 (enExample)
JP (1) JP2023505169A (enExample)
KR (1) KR20220109435A (enExample)
CN (1) CN115052626A (enExample)
AU (1) AU2020397416A1 (enExample)
BR (1) BR112022010425A2 (enExample)
CA (1) CA3163356A1 (enExample)
IL (1) IL293449A (enExample)
WO (1) WO2021110561A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230242655A1 (en) 2019-12-03 2023-08-03 Evotec International Gmbh Interferon-associated antigen binding proteins and uses thereof
IL298136A (en) 2020-05-13 2023-01-01 Bonum Therapeutics Inc Preparations of protein complexes and methods of using them
EP4351732A1 (en) * 2021-06-09 2024-04-17 Evotec International GmbH Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection
WO2024126294A1 (en) * 2022-12-13 2024-06-20 Evotec International Gmbh Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection
WO2024126293A1 (en) * 2022-12-13 2024-06-20 Evotec International Gmbh Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection
WO2024126289A1 (en) * 2022-12-13 2024-06-20 Evotec International Gmbh Interferon-associated antigen binding proteins for use for the treatment or prevention of influenza virus infection
WO2024213635A1 (en) * 2023-04-12 2024-10-17 Evotec International Gmbh Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatitis delta virus infection

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
IL79289A (en) 1985-07-05 1992-01-15 Whitehead Biomedical Inst Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
EP0281604B1 (en) 1986-09-02 1993-03-31 Enzon Labs Inc. Single polypeptide chain binding molecules
US5750172A (en) 1987-06-23 1998-05-12 Pharming B.V. Transgenic non human mammal milk
ATE117375T1 (de) 1987-09-11 1995-02-15 Whitehead Biomedical Inst Transduktionsveränderte fibroblasten und ihre anwendung.
JP2914692B2 (ja) 1987-12-11 1999-07-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 内皮細胞の遺伝子修飾
WO1989007136A2 (en) 1988-02-05 1989-08-10 Whitehead Institute For Biomedical Research Modified hepatocytes and uses therefor
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
ES2096750T3 (es) 1990-10-31 1997-03-16 Somatix Therapy Corp Vectores retroviricos utiles para la terapia genica.
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
WO1994019935A1 (en) 1993-03-09 1994-09-15 Genzyme Corporation Isolation of components of interest from milk
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
GB9524973D0 (en) 1995-12-06 1996-02-07 Lynxvale Ltd Viral vectors
US6133426A (en) 1997-02-21 2000-10-17 Genentech, Inc. Humanized anti-IL-8 monoclonal antibodies
US6517529B1 (en) 1999-11-24 2003-02-11 Radius International Limited Partnership Hemodialysis catheter
MX2008013993A (es) * 2006-05-03 2009-05-11 Univ Colorado Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
JP2013541937A (ja) * 2010-08-05 2013-11-21 エフ.ホフマン−ラ ロシュ アーゲー 抗mhc抗体−抗ウイルス性サイトカイン融合タンパク質
ES2985566T3 (es) * 2016-03-04 2024-11-06 Univ Rockefeller Anticuerpos contra CD40 con actividad agonista mejorada
EP3439696A4 (en) * 2016-04-06 2019-12-25 University of Washington THERAPEUTIC VACCINE AGAINST THE HEPATITIS B VIRUS (HBV) USING THE HBV CORE ANTIGEN
WO2018087345A1 (en) * 2016-11-14 2018-05-17 F. Hoffmann-La Roche Ag COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON
JP7676150B2 (ja) * 2018-06-01 2025-05-14 サノフイ B型肝炎ウイルス感染を治療するための併用療法

Similar Documents

Publication Publication Date Title
JP2023505169A5 (enExample)
JP2018535650A5 (enExample)
JP2025036561A5 (enExample)
FI4045533T3 (fi) Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2)
JP2020079252A5 (enExample)
JP2022540083A5 (enExample)
JP2022079549A5 (enExample)
JP2012504955A5 (enExample)
JP2021524267A5 (enExample)
JP2010516229A5 (enExample)
JP2018108081A5 (enExample)
JP2018521638A5 (enExample)
RU2009136677A (ru) Рекомбинантные антитела для лечения респираторно-синцитиальных вирусных инфекций
JP2023071956A5 (enExample)
JP2011528902A5 (enExample)
JP2017533694A5 (enExample)
JP2010534478A5 (enExample)
RU2011105062A (ru) Нейтрализующие антитела против вируса гриппа а и их использование
JP2006512899A5 (enExample)
JP2011528901A5 (enExample)
RU2012112829A (ru) Анти-gitr-антитела
JP2025032102A5 (enExample)
JP2017537084A5 (enExample)
RU2765878C2 (ru) Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний
JP2018522540A5 (enExample)